Cited 727 times in
Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.